Canada's Role in the Development of the SARSCoV2 Jab

Dr David Martin discusses the University of British Columbia's role in developing the lipid nano-particle technology used to deliver the spike proteins in the jab, as well as Justin Trudeau's financial stake in his self-proclaimed "pathway to the new normal".
Excerpt from Vaccine Choice Canada's webinar August 18th 2021.